The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | 2,910 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 64 | 45,960 | SH | SOLE | 45,960 | 0 | 0 | ||
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 11,165 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| GLOBUS MED INC | CL A | 379577208 | 26,949 | 373,254 | SH | SOLE | 373,254 | 0 | 0 | ||
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 1,484 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,931 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 24 | 33,331 | SH | SOLE | 33,331 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 2,916 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 1,940 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 2,931 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 18,115 | 758,253 | SH | SOLE | 758,253 | 0 | 0 | ||
| SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 1,331 | 1,165,832 | SH | SOLE | 1,165,832 | 0 | 0 | ||
| SURROZEN INC | COM | 86889P109 | 22,359 | 3,497,500 | SH | SOLE | 3,497,500 | 0 | 0 | ||
| TANDEM DIABETES CARE INC | COM NEW | 875372203 | 45,256 | 300,664 | SH | SOLE | 300,664 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 12,930 | 59,838 | SH | SOLE | 59,838 | 0 | 0 | ||